businesspress24.com - Leading Military Fabric Supplier Schedules Scale-Up Trial of Alexiflam(TM) Technology
 

Leading Military Fabric Supplier Schedules Scale-Up Trial of Alexiflam(TM) Technology

ID: 1376922

(firmenpresse) - PERTH, AUSTRALIA and GREER, SC -- (Marketwired) -- 08/04/15 -- (ASX: AJX) (OTCQX: AXXIY) is pleased to announce another leading supplier to the US Defense Sector has provided an initial purchase order for the shipment of Alexiflam™ Fire Retardant (FR) technology for a scale-up trial for Nylon/Cotton military uniforms.

Pending the successful trial, initial revenue of circa US$1MM could be received by Alexium to fulfill next stage testing for this Customer''s products by early 2016. Shortly thereafter, a comprehensive agreement with this Customer could address 5% per annum of the global military market, currently valued at US$240MM per annum.

This Customer scale-up trial builds off our efforts with the US Army Natick Soldier Systems Centre (Natick) to be a key supplier of Eco-Friendly FR solutions in US Department of Defense military uniform programs. "Having yet another important supplier to the military market moving to a scale-up trial shows that our Environmentally Friendly Nylon/Cotton FR Alexiflam™ technology meets the rigorous requirements of flame retardancy for military uniforms," said Steve Gravlee, VP of Sales.

John Stelling, Alexium''s Coordinator of Military Markets, added, "This high level of performance combined with cost effectiveness and ease of production transition has proven that Alexiflam™ has become one of the best new products for military needs in this area."

Alexium will provide further information as we move to following stages.

For more information, please visit

Alexium International Group Limited (ASX: AJX) (OTCQX: AXXIY) holds proprietary patent applications for a process developed initially by the U.S. Department of Defense, which allows for the surface modification and attachment of nano-particles or multiple chemical functional groups to surfaces or substrates to provide functions such as fire retardancy, water proofing, oil proofing, and anti-microbial treatments. Applications under development include but are not limited to textiles, paints, and packaging, glass and building materials. Alexium''s fire retardant chemical treatment are currently marketed for different fabric markets under the Ascalon™, Nycolon™, Nuvalon™, and Polytron™, Omnitron™ and Bactron™ trademarks.





This press release contains "forward-looking statements." Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company''s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.



Nick Clark
Chief Executive Officer

U.S.: +1 864.991.6687

Bradi Dobson
Marketing Specialist


8 Distribution Court
Greer, SC 29650
T: +1 864.416.1060
F: +1 864.752.6465

148 Milestone Way
Greenville, SC 29615
T: +1 864.603.1165
F: +1 864.752.6465

Matt Wright
Investor Relations

AUS: +61 451.896.420

ABN: 91 064 820 408
ASX: AJX


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Clorox Reports 4 Percent Sales Growth and 11 Percent EPS Growth in Q4; Provides Fiscal Year 2016 Outlook
Thermon Reports First Quarter Results
Bereitgestellt von Benutzer: Marketwired
Datum: 04.08.2015 - 17:00 Uhr
Sprache: Deutsch
News-ID 1376922
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

PERTH, AUSTRALIA and GREER, SC


Phone:

Kategorie:

Specialty Chemicals


Anmerkungen:


Diese Pressemitteilung wurde bisher 265 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Leading Military Fabric Supplier Schedules Scale-Up Trial of Alexiflam(TM) Technology
"
steht unter der journalistisch-redaktionellen Verantwortung von

Alexium International Group (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Alexium International Group



 

Who is online

All members: 10 563
Register today: 0
Register yesterday: 2
Members online: 0
Guests online: 64


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.